Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments
Vitiligo is a chronic autoimmune dermatosis of which the pathogenesis remains scarcely known. A wide variety of clinical studies have been proposed to investigate the immune mediators which have shown the most recurrency. However, such trials have produced controversial results. The aim of this revi...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d5e815679d1b437d9195910555b5dbb6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d5e815679d1b437d9195910555b5dbb6 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d5e815679d1b437d9195910555b5dbb62021-11-11T16:53:55ZRole of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments10.3390/ijms2221114291422-00671661-6596https://doaj.org/article/d5e815679d1b437d9195910555b5dbb62021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11429https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Vitiligo is a chronic autoimmune dermatosis of which the pathogenesis remains scarcely known. A wide variety of clinical studies have been proposed to investigate the immune mediators which have shown the most recurrency. However, such trials have produced controversial results. The aim of this review is to summarize the main factors involved in the pathogenesis of vitiligo, the latest findings regarding the cytokines involved and to evaluate the treatments based on the use of biological drugs in order to stop disease progression and achieve repigmentation. According to the results, the most recurrent studies dealt with inhibitors of IFN-gamma and TNF-alpha. It is possible that, given the great deal of cytokines involved in the lesion formation process of vitiligo, other biologics could be developed in the future to be used as adjuvants and/or to entirely replace the treatments that have proven to be unsatisfactory so far.Paolo CusturoneLuca Di BartolomeoNatasha IrreraFrancesco BorgiaDomenica AltavillaAlessandra BittoGiovanni PallioFrancesco SquadritoMario VaccaroMDPI AGarticlevitiligointerleukinsbiologicsbiological drugsoxidative stressautoimmune diseasesBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11429, p 11429 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
vitiligo interleukins biologics biological drugs oxidative stress autoimmune diseases Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
vitiligo interleukins biologics biological drugs oxidative stress autoimmune diseases Biology (General) QH301-705.5 Chemistry QD1-999 Paolo Custurone Luca Di Bartolomeo Natasha Irrera Francesco Borgia Domenica Altavilla Alessandra Bitto Giovanni Pallio Francesco Squadrito Mario Vaccaro Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments |
description |
Vitiligo is a chronic autoimmune dermatosis of which the pathogenesis remains scarcely known. A wide variety of clinical studies have been proposed to investigate the immune mediators which have shown the most recurrency. However, such trials have produced controversial results. The aim of this review is to summarize the main factors involved in the pathogenesis of vitiligo, the latest findings regarding the cytokines involved and to evaluate the treatments based on the use of biological drugs in order to stop disease progression and achieve repigmentation. According to the results, the most recurrent studies dealt with inhibitors of IFN-gamma and TNF-alpha. It is possible that, given the great deal of cytokines involved in the lesion formation process of vitiligo, other biologics could be developed in the future to be used as adjuvants and/or to entirely replace the treatments that have proven to be unsatisfactory so far. |
format |
article |
author |
Paolo Custurone Luca Di Bartolomeo Natasha Irrera Francesco Borgia Domenica Altavilla Alessandra Bitto Giovanni Pallio Francesco Squadrito Mario Vaccaro |
author_facet |
Paolo Custurone Luca Di Bartolomeo Natasha Irrera Francesco Borgia Domenica Altavilla Alessandra Bitto Giovanni Pallio Francesco Squadrito Mario Vaccaro |
author_sort |
Paolo Custurone |
title |
Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments |
title_short |
Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments |
title_full |
Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments |
title_fullStr |
Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments |
title_full_unstemmed |
Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments |
title_sort |
role of cytokines in vitiligo: pathogenesis and possible targets for old and new treatments |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/d5e815679d1b437d9195910555b5dbb6 |
work_keys_str_mv |
AT paolocusturone roleofcytokinesinvitiligopathogenesisandpossibletargetsforoldandnewtreatments AT lucadibartolomeo roleofcytokinesinvitiligopathogenesisandpossibletargetsforoldandnewtreatments AT natashairrera roleofcytokinesinvitiligopathogenesisandpossibletargetsforoldandnewtreatments AT francescoborgia roleofcytokinesinvitiligopathogenesisandpossibletargetsforoldandnewtreatments AT domenicaaltavilla roleofcytokinesinvitiligopathogenesisandpossibletargetsforoldandnewtreatments AT alessandrabitto roleofcytokinesinvitiligopathogenesisandpossibletargetsforoldandnewtreatments AT giovannipallio roleofcytokinesinvitiligopathogenesisandpossibletargetsforoldandnewtreatments AT francescosquadrito roleofcytokinesinvitiligopathogenesisandpossibletargetsforoldandnewtreatments AT mariovaccaro roleofcytokinesinvitiligopathogenesisandpossibletargetsforoldandnewtreatments |
_version_ |
1718432206450327552 |